| A global metagenomic map of urban microbiomes and antimicrobial resistance D Danko, D Bezdan, EE Afshin, S Ahsanuddin, C Bhattacharya, DJ Butler, ... Cell 184 (13), 3376-3393. e17, 2021 | 271 | 2021 |
| Clinical impact of sexual dimorphism in non‐alcoholic fatty liver disease (NAFLD) and non‐alcoholic steatohepatitis (NASH) P Burra, D Bizzaro, A Gonta, S Shalaby, M Gambato, MC Morelli, ... Liver International 41 (8), 1713-1733, 2021 | 110 | 2021 |
| Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ... Gut 71 (3), 593-604, 2022 | 94 | 2022 |
| A prediction model for successful anticoagulation in cirrhotic portal vein thrombosis KI Rodriguez-Castro, A Vitale, M Fadin, S Shalaby, P Zerbinati, MT Sartori, ... European journal of gastroenterology & hepatology 31 (1), 34-42, 2019 | 85 | 2019 |
| Endothelial damage of the portal vein is associated with heparin-like effect in advanced stages of cirrhosis S Shalaby, P Simioni, E Campello, L Spiezia, S Gavasso, D Bizzaro, ... Thrombosis and Haemostasis 120 (08), 1173-1181, 2020 | 65 | 2020 |
| Dropout rate from the liver transplant waiting list because of hepatocellular carcinoma progression in hepatitis C virus–infected patients treated with direct‐acting antivirals A Zanetto, S Shalaby, A Vitale, C Mescoli, A Ferrarese, M Gambato, ... Liver Transplantation 23 (9), 1103-1112, 2017 | 63 | 2017 |
| Reversal of hypercoagulability in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals FP Russo, A Zanetto, E Campello, C Bulato, S Shalaby, L Spiezia, ... Liver International 38 (12), 2210-2218, 2018 | 54 | 2018 |
| Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections A Zanetto, E Campello, C Bulato, S Gavasso, G Saggiorato, S Shalaby, ... JHEP Reports 4 (7), 100493, 2022 | 43 | 2022 |
| Hepatitis C virus related cirrhosis decreased as indication to liver transplantation since the introduction of direct-acting antivirals: A single-center study A Ferrarese, G Germani, M Gambato, FP Russo, M Senzolo, A Zanetto, ... World Journal of Gastroenterology 24 (38), 4403, 2018 | 40 | 2018 |
| Increased cancer risk in patients undergoing dialysis: a population-based cohort study in North-Eastern Italy M Taborelli, F Toffolutti, S Del Zotto, E Clagnan, L Furian, P Piselli, ... BMC nephrology 20, 1-8, 2019 | 39 | 2019 |
| Survival after the diagnosis of de novo malignancy in liver transplant recipients M Taborelli, P Piselli, GM Ettorre, U Baccarani, P Burra, A Lauro, ... International Journal of Cancer 144 (2), 232-239, 2019 | 38 | 2019 |
| Long-term care of transplant recipients: de novo: neoplasms after liver transplantation P Burra, S Shalaby, A Zanetto Current Opinion in Organ Transplantation 23 (2), 187-195, 2018 | 37 | 2018 |
| New indications for liver transplantation A Zanetto, S Shalaby, M Gambato, G Germani, M Senzolo, D Bizzaro, ... Journal of Clinical Medicine 10 (17), 3867, 2021 | 34 | 2021 |
| Risk of virus and non‐virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985–2014 M Taborelli, P Piselli, GM Ettorre, A Lauro, L Galatioto, U Baccarani, ... International journal of cancer 143 (7), 1588-1594, 2018 | 34 | 2018 |
| More pronounced hypercoagulable state and hypofibrinolysis in patients with cirrhosis with versus without HCC A Zanetto, E Campello, C Bulato, S Gavasso, G Saggiorato, S Shalaby, ... Hepatology Communications 5 (12), 1987-2000, 2021 | 30 | 2021 |
| Influence of hepatocellular carcinoma on platelet aggregation in cirrhosis A Zanetto, M Senzolo, E Campello, C Bulato, S Gavasso, S Shalaby, ... Cancers 13 (5), 1150, 2021 | 29 | 2021 |
| Recent advances in the management of acute variceal hemorrhage A Zanetto, S Shalaby, P Feltracco, M Gambato, G Germani, FP Russo, ... Journal of Clinical Medicine 10 (17), 3818, 2021 | 28 | 2021 |
| Management of bacterial infection in the liver transplant candidate A Ferrarese, A Zanetto, C Becchetti, SS Sciarrone, S Shalaby, G Germani, ... World Journal of Hepatology 10 (2), 222, 2018 | 24 | 2018 |
| Comparison of fondaparinux and low-molecular-weight heparin in the treatment of portal vein thrombosis in cirrhosis M Senzolo, S Piano, S Shalaby, M Tonon, S Tonello, A Zanetto, ... The American Journal of Medicine 134 (10), 1278-1285. e2, 2021 | 21 | 2021 |
| Changes in plasma circulating microvesicles in patients with HCV‐related cirrhosis after treatment with direct‐acting antivirals E Campello, CM Radu, A Zanetto, C Bulato, S Shalaby, L Spiezia, ... Liver International 40 (4), 913-920, 2020 | 19 | 2020 |
